DK0683791T3 - Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf - Google Patents
Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser derafInfo
- Publication number
- DK0683791T3 DK0683791T3 DK94906253T DK94906253T DK0683791T3 DK 0683791 T3 DK0683791 T3 DK 0683791T3 DK 94906253 T DK94906253 T DK 94906253T DK 94906253 T DK94906253 T DK 94906253T DK 0683791 T3 DK0683791 T3 DK 0683791T3
- Authority
- DK
- Denmark
- Prior art keywords
- albumin
- pct
- protein composition
- agent
- aqueous
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 102000003886 Glycoproteins Human genes 0.000 title abstract 2
- 108090000288 Glycoproteins Proteins 0.000 title abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 5
- 108010088751 Albumins Proteins 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- 230000001376 precipitating effect Effects 0.000 abstract 3
- 238000001042 affinity chromatography Methods 0.000 abstract 2
- 210000002381 plasma Anatomy 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 238000011210 chromatographic step Methods 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9301399A FR2701263B1 (fr) | 1993-02-09 | 1993-02-09 | Procédé d'obtention d'une composition aqueuse protéinique, composition correspondante, glycoprotéine contenue et son utilisation pour la stabilisation de l'albumine et la détection ou le dosage d'anticorps. |
| PCT/FR1994/000143 WO1994018228A1 (fr) | 1993-02-09 | 1994-02-09 | Composition aqueuse proteinique, glycoproteine contenue, procede d'obtention et utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0683791T3 true DK0683791T3 (da) | 2004-05-03 |
Family
ID=9443864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94906253T DK0683791T3 (da) | 1993-02-09 | 1994-02-09 | Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5859213A (da) |
| EP (1) | EP0683791B1 (da) |
| AT (1) | ATE263779T1 (da) |
| DE (1) | DE69433682T2 (da) |
| DK (1) | DK0683791T3 (da) |
| ES (1) | ES2215164T3 (da) |
| FR (1) | FR2701263B1 (da) |
| WO (1) | WO1994018228A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100361933B1 (ko) * | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트 |
| JP3308173B2 (ja) * | 1996-11-07 | 2002-07-29 | 松下電器産業株式会社 | 尿検査方法およびそれに用いる尿検査装置 |
| US6858210B1 (en) | 1998-06-09 | 2005-02-22 | La Jolla Pharmaceutical Co. | Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same |
| US6458953B1 (en) * | 1998-12-09 | 2002-10-01 | La Jolla Pharmaceutical Company | Valency platform molecules comprising carbamate linkages |
| CA2376057A1 (en) * | 1999-06-08 | 2000-12-14 | La Jolla Pharmaceutical Company | Valency platform molecules comprising aminooxy groups |
| CA2414076A1 (en) | 2000-06-08 | 2001-12-13 | La Jolla Pharmaceutical Company | Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| FR2827047B1 (fr) * | 2001-07-03 | 2003-09-26 | Apoh Technollgies Sa | Procede de separation et/ou detection et/ou identification et/ou quantification de proteines prions |
| DK1853631T3 (da) * | 2005-01-24 | 2016-03-29 | Univ Texas | Fc-FUSION-KONSTRUKTER, DER BINDES TIL PHOSPHATIDYLSERIN, OG TERAPEUTISK ANVENDELSE HERAF |
| AU2012253595B2 (en) * | 2011-05-10 | 2016-10-20 | Advanced Liquid Logic, Inc. | Enzyme concentration and assays |
| US9513253B2 (en) | 2011-07-11 | 2016-12-06 | Advanced Liquid Logic, Inc. | Droplet actuators and techniques for droplet-based enzymatic assays |
| CA3188995A1 (en) | 2020-08-11 | 2022-02-17 | Elias STEFAS | Method for separation and/or detection and/or in vitro quantification of infectious compounds in biological material |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN150740B (da) * | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
| FR2541593B1 (fr) * | 1983-02-25 | 1988-06-17 | Rhone Poulenc Spec Chim | Support mineral poreux pour la purification et le fractionnement des macromolecules biologiques |
-
1993
- 1993-02-09 FR FR9301399A patent/FR2701263B1/fr not_active Expired - Fee Related
-
1994
- 1994-02-09 US US08/495,508 patent/US5859213A/en not_active Expired - Fee Related
- 1994-02-09 WO PCT/FR1994/000143 patent/WO1994018228A1/fr active IP Right Grant
- 1994-02-09 DK DK94906253T patent/DK0683791T3/da active
- 1994-02-09 AT AT94906253T patent/ATE263779T1/de not_active IP Right Cessation
- 1994-02-09 EP EP94906253A patent/EP0683791B1/fr not_active Expired - Lifetime
- 1994-02-09 DE DE69433682T patent/DE69433682T2/de not_active Expired - Fee Related
- 1994-02-09 ES ES94906253T patent/ES2215164T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0683791A1 (fr) | 1995-11-29 |
| FR2701263A1 (fr) | 1994-08-12 |
| DE69433682T2 (de) | 2005-04-21 |
| ES2215164T3 (es) | 2004-10-01 |
| DE69433682D1 (de) | 2004-05-13 |
| EP0683791B1 (fr) | 2004-04-07 |
| WO1994018228A1 (fr) | 1994-08-18 |
| ATE263779T1 (de) | 2004-04-15 |
| US5859213A (en) | 1999-01-12 |
| FR2701263B1 (fr) | 1995-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Weiss et al. | Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography | |
| Givol et al. | General method for the specific isolation of peptides containing modified residues, using insoluble antibody columns | |
| Dunn et al. | The α2-Macroglobulin of Human Plasma: I. ISOLATION AND COMPOSITION | |
| Fearon | Purification of C3b inactivator and demonstration of its two polypeptide chain structure | |
| US4217339A (en) | Glycoprotein and process for isolating it | |
| Domenicucci et al. | Characterization of porcine osteonectin extracted from foetal calvariae | |
| Michaelis | Partial purification and characterization of a glutamate-binding membrane glycoprotein from rat brain | |
| JP2509407B2 (ja) | 生物学的に活性な化合物の単離方法 | |
| Perez et al. | Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide (" cochemotaxin") in normal serum and plasma. | |
| Kiron et al. | Purification and properties of a soluble angiotensin II-binding protein from rabbit liver | |
| US4269825A (en) | New glycoprotein and process for isolating it | |
| DK0683791T3 (da) | Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf | |
| DAHR et al. | High frequency antigens of human erythrocyte membrane sialoglycoproteins, V. Characterization of the Gerbich blood group antigens: Ge2 and Ge3 | |
| Rauh et al. | Calmodulin is a major component of extruded trichocysts from Paramecium tetraurelia. | |
| Gordon et al. | Refinement of fluorescent antibody by gel filtration. | |
| Gonmori et al. | Properties of human tissue thromboplastins from brain, lung, arteries, and placenta | |
| Stathakis et al. | Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains | |
| Calero et al. | Location of a novel type of interpolypeptide chain linkage in the human protein HC-IgA complex (HC-IgA) and identification of a heterogeneous chromophore associated with the complex. | |
| CHU et al. | Interaction of parathyroid hormone with membranes of kidney cortex: Degradation of the hormone and activation of adenylate cyclase | |
| Kitagawa et al. | Separation of antibodies into fractions with different binding properties | |
| US4018885A (en) | Steroid-binding globulin and process for preparing it and antibodies thereto | |
| BEALL et al. | Serum protein inhibition of thyrotropin binding to human thyroid tissue | |
| JP2672961B2 (ja) | 第▲ｖｉｉｉ▼：ｃ因子欠乏血漿の調製方法 | |
| Minta | Purification of native properdin by reversed affinity chromatography and its activation by proteolytic enzymes | |
| Fehm et al. | Influence of plasma on ACTH stimulated corticosterone production of isolated adrenal cells |